Cyclin-dependent kinase 1 (CDK1), a key player which promotes G2-M transition, regulates G1 progress and G1-S transition through associating with multiple interphase cyclins, has been reported to be upregulated in CRC circulating tumor cells [3]. The gene discussed is CDK1; the disease is neoplasm.